VCEL Vericel Corp

VCEL financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 887359 Exchange: Nasdaq SIC: 2836 (Biological Products, (No Diagnostic Substances))
Showing 3 of 17 annual and 0 of 63 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Large accelerated filer
Entity Type
Operating
Public Float
$2.10B (Jun 2025)
Industry (SIC)
2836 Biological Products, (No Diagnostic Substances)
Incorporated
MI
Fiscal Year End
December (1231)
Phone
6175885555
EIN
943096597
Headquarters
BURLINGTON, MA, 01803
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names: AASTROM BIOSCIENCES INC (1996–2014)

▼ Key Metrics (TTM)

As of Jun 30, 2026
Financials
Revenue
$306.30M
Net Income
$24.22M
Total Assets
$502.87M
Total Equity
$370.04M
Total Debt
-
Free Cash Flow
$61.66M
Ratios
Gross Margin
74.6%
Operating Margin
6%
Net Margin
7.9%
Return on Equity
6.5%
Return on Assets
4.8%
Current Ratio
5.04x
FCF / Assets
12.3%

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

Vericel Corp generated $276.26M of revenue in fiscal 2025, with net income of $16.52M and an operating cash inflow of $51.91M. The $276.26M revenue base provides substantial context for the company’s earnings, cash generation, and capital requirements. Revenue was 16.5% above fiscal 2024 revenue of $237.22M, marking a year-over-year increase. The company reported diluted EPS of $0.32, adding a shareholder-level measure to the absolute income figures considered below. Against diluted EPS of $0.20 in fiscal 2024, the current result was 60.0% higher. The revenue-to-assets relationship was 0.57x, showing the sales generated relative to the resources carried on the balance sheet.

Profitability

Gross profit was $205.60M, representing the portion of revenue remaining after the reported cost of revenue and before operating expenses. The gross-profit relationship equaled 74.4% of revenue, quantifying the portion retained before operating expenses were recognized. Operating income was $11.04M, the earnings remaining from reported operations after the company’s recognized operating cost structure. Operating margin measured 4.0%, showing the portion of revenue preserved after the full set of operating costs. After all reported below-operating-line items, the company recorded net income of $16.52M for the fiscal year. Measured against reported revenue, net income produced a 6.0% margin after operating costs and the remaining recognized items. Before income taxes, the company reported $17.38M of earnings, providing a bridge between the operating result and final net income. Measured against revenue, pretax income equaled 6.3%, adding a pre-tax profitability layer between revenue and net income. Income tax expense totaled $859.00K, providing the reported tax component that separates pretax and after-tax earnings. Relative to pretax income, the tax provision measured 4.9%, quantifying the portion of pre-tax earnings paid in income tax. Net income equaled 4.7% of period-end equity, showing the earnings generated on shareholders’ book capital. The net-income-to-assets relationship measured 3.4%, showing earnings relative to the full balance sheet.

Liquidity and Capital Structure

The company held $487.97M of assets against $133.33M of liabilities and $354.64M of equity, revealing how the asset base was financed. Current assets were $247.44M against $49.15M of current liabilities, framing the resources and obligations classified within the near-term balance-sheet horizon. Current assets covered current liabilities by 5.03x, leaving a positive buffer for near-term obligations. Reported cash and equivalents were $100.09M, separating immediately recognizable cash resources from the rest of the current-asset base. Measured only with cash and equivalents, coverage of current liabilities was 203.7%, excluding receivables and other current assets. Relative to total assets, liabilities measured 27.3%, complementing the separate equity-based view of the company’s capital structure. The cash-to-assets relationship was 20.5%, comparing reported cash and equivalents with the full positive asset balance. The asset base changed 12.8% from $432.72M in fiscal 2024, leaving current total assets higher year over year. Against $291.97M of equity in fiscal 2024, the current book-equity balance moved 21.5% and ended higher.

Cash Flow and Earnings Quality

Operating activities produced a cash inflow of $51.91M, giving the cash-flow counterpart to the accrual-based profit measures reported for the year. The operating-cash-flow-to-net-income relationship was 3.14x, comparing cash generated by operations with the bottom-line earnings result. Capital expenditures used $27.16M, identifying the reported investment outflow deducted from operating cash flow in the free-cash-flow calculation. Capital expenditures represented 52.3% of operating cash flow, leaving the remainder available as free cash flow. Free cash flow came to $24.75M, leaving a positive amount after capital expenditures. The free-cash-flow margin was 9.0%, measuring cash remaining after capital spending against revenue. Free cash flow equaled 5.1% of total assets, relating post-investment cash generation to the company’s resource base.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual (FY)
Quarterly 🔒
Chart 🔒
Annual financial statements for Vericel Corp
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $276.26M $237.22M $197.52M
Cost of Revenue $70.66M $65.12M $61.94M
Gross Profit $205.60M $172.11M $135.58M
OPERATING EXPENSES
R&D Expense $27.56M $24.80M $21.04M
SG&A Expense $166.99M $142.79M $121.00M
Other Operating Expenses (derived) $0 $0 $0
Operating Income $11.04M $4.52M $-6.46M
NON-OPERATING INCOME / EXPENSE
Interest Expense - - $600.00K
Interest Income $7.01M $6.41M $4.63M
Other Income/Expense $-44.00K $195.00K $64.00K
Pretax Income $17.38M $10.51M $-2.37M
Income Tax $859.00K $148.00K $814.00K
Net Income $16.52M $10.36M $-3.18M
PER SHARE & SUPPLEMENTAL
Diluted EPS $0.32 $0.20 $-0.07
Diluted Shares 52.15M 51.68M 47.59M
EBITDA $22.59M $10.02M $-1.83M
Depreciation & Amortization $11.54M $5.50M $4.63M
Balance Sheet
ASSETS
Cash & Equivalents $100.09M $74.52M $69.09M
Short-term Investments $37.41M $41.69M $40.47M
Accounts Receivable $84.63M $61.38M $58.36M
Inventory $17.56M $17.37M $13.09M
Other Current Assets $7.74M $7.29M $6.85M
Current Assets $247.44M $212.78M $205.63M
PP&E (Net) $108.40M $103.16M $41.64M
Intangible Assets $5.63M $6.25M $6.88M
Other Noncurrent Assets $341.00K $556.00K $771.00K
Noncurrent Assets $240.53M $219.95M $148.03M
Total Assets $487.97M $432.72M $353.66M
LIABILITIES
Accounts Payable $15.83M $23.85M $22.35M
Other Current Liabilities $116.00K $116.00K $0
Current Liabilities $49.15M $50.29M $45.75M
Other Noncurrent Liabilities $1.90M $876.00K $100.00K
Noncurrent Liabilities $84.18M $90.47M $81.96M
Total Liabilities $133.33M $140.76M $127.71M
EQUITY
Common Stock $730.66M $684.78M $629.23M
Retained Earnings $-376.30M $-392.82M $-403.18M
Accumulated OCI $275.00K $4.00K $-100.00K
Total Equity $354.64M $291.97M $225.95M
Total Liabilities & Equity $487.97M $432.72M $353.66M
SUPPLEMENTAL
Shares Outstanding 50.62M 49.63M 47.83M
Check: A − (L + E + NCI) - - -
Cash Flow Statement
Cash from Operations $51.91M $58.16M $35.31M
Capital Expenditures $27.16M $63.97M $20.01M
Cash from Investing $-43.94M $-79.03M $-3.13M
Cash from Financing $7.07M $19.05M $3.62M
Free Cash Flow $24.75M $-5.81M $15.30M
Beginning Cash (CFS) $85.05M $86.87M -
Net Change in Cash $15.04M $-1.82M -
Effect of FX on Cash - - -
Calculated Ending Cash $100.09M $85.05M -
Cash per BS $100.09M $74.52M $69.09M
Cash scope difference (CFS − BS) - $10.53M $17.78M
Cash per CFS $100.09M $85.05M $86.87M

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is Vericel Corp's annual revenue?

Vericel Corp reported $306.30M in revenue for trailing twelve months (ending June 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is Vericel Corp profitable?

Yes. Vericel Corp reported $24.22M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.

Does Vericel Corp generate free cash flow?

Yes. Free cash flow was $61.66M for trailing twelve months. Operating cash flow was $69.67M.